BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15512363)

  • 21. The effects of oestrogens and anti-oestrogens on cognition.
    Shilling V; Jenkins V; Fallowfield L; Howell A
    Breast; 2001 Dec; 10(6):484-91. PubMed ID: 14965628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bonistein (synthetic genistein), a food component in development for a bone health nutraceutical.
    Ullmann U; Bendik I; Flühmann B
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 1():79-95. PubMed ID: 15800387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soy isoflavones in the management of postmenopausal osteoporosis.
    Atmaca A; Kleerekoper M; Bayraktar M; Kucuk O
    Menopause; 2008; 15(4 Pt 1):748-57. PubMed ID: 18277912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylaxis approach to a-symptomatic post-menopausal women: breast cancer.
    Aguas F; Martins A; Gomes TP; de Sousa M; Silva DP;
    Maturitas; 2005 Nov; 52 Suppl 1():S23-31. PubMed ID: 16126355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition.
    Zhao L; Brinton RD
    Expert Rev Neurother; 2007 Nov; 7(11):1549-64. PubMed ID: 17997703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
    Velentzis LS; Woodside JV; Cantwell MM; Leathem AJ; Keshtgar MR
    Eur J Cancer; 2008 Sep; 44(13):1799-806. PubMed ID: 18614351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the oestrogen action in experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Brouchet L; Tremollières F; Laurell H; Lenfant F; Gadeau AP; Guery JC; Gourdy P
    Fundam Clin Pharmacol; 2006 Dec; 20(6):539-48. PubMed ID: 17109647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effects of phytoestrogen therapy on the endometrium in postmenopausal women].
    Caserta L; Caserta R; Torella M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2005 Oct; 57(5):551-5. PubMed ID: 16205600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phytoestrogens--an alternative to hormonal replacement therapy].
    Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
    Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells.
    Edmunds KM; Holloway AC; Crankshaw DJ; Agarwal SK; Foster WG
    Reprod Nutr Dev; 2005; 45(6):709-20. PubMed ID: 16285913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early life and adult exposure to isoflavones and breast cancer risk.
    Tomar RS; Shiao R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):113-73. PubMed ID: 18569328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
    Matsumura A; Ghosh A; Pope GS; Darbre PD
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phytoestrogens and endometrial hyperplasia.
    Prescrire Int; 2006 Apr; 15(82):62-3. PubMed ID: 16607696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ERalpha- and ERbeta-mRNA and protein expresion.
    Staar S; Richter DU; Makovitzky J; Briese V; Bergemann C
    Anticancer Res; 2005; 25(3A):1713-8. PubMed ID: 16033089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
    Messina M; McCaskill-Stevens W; Lampe JW
    J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soy-based formulas and phyto-oestrogens: a safety profile.
    Miniello VL; Moro GE; Tarantino M; Natile M; Granieri L; Armenio L
    Acta Paediatr Suppl; 2003 Sep; 91(441):93-100. PubMed ID: 14599051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal hormone therapy and risk of breast cancer.
    Chen FP
    Chang Gung Med J; 2009; 32(2):140-7. PubMed ID: 19403003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.